A new case of limb girdle muscular dystrophy 2G in a Greek patient, founder effect and review of the literature

Roberta Brusa, Francesca Magri, Dimitra Papadimitriou, Alessandra Govoni, Roberto Del Bo, Patrizia Ciscato, Marco Savarese, Claudia Cinnante, Maggie C. Walter, Angela Abicht, Stefanie Bulst, Stefania Corti, Maurizio Moggio, Nereo Bresolin, Vincenzo Nigro, Giacomo Pietro Comi

Research output: Contribution to journalArticle

Abstract

Limb girdle muscular dystrophy (LGMD) type 2G is a rare form of muscle disease, described only in a few patients worldwide, caused by mutations in TCAP gene, encoding the protein telethonin. It is characterised by proximal limb muscle weakness associated with distal involvement of lower limbs, starting in the first or second decade of life. We describe the case of a 37-year-old woman of Greek origin, affected by disto-proximal lower limb weakness. No cardiac or respiratory involvement was detected. Muscle biopsy showed myopathic changes with type I fibre hypotrophy, cytoplasmic vacuoles, lipid overload, multiple central nuclei and fibre splittings; ultrastructural examination showed metabolic abnormalities. Next generation sequencing analysis detected a homozygous frameshift mutation in the TCAP gene (c.90_91del), previously described in one Turkish family. Immunostaining and Western blot analysis showed complete absence of telethonin. Interestingly, Single Nucleotide Polymorphism analysis of the 10 Mb genomic region containing the TCAP gene showed a shared homozygous haplotype of both the Greek and the Turkish patients, thus suggesting a possible founder effect of TCAP gene c.90_91del mutation in this part of the Mediterranean area.

Original languageEnglish
Pages (from-to)532-537
JournalNeuromuscular Disorders
Volume28
Issue number6
DOIs
Publication statusPublished - 2018

Fingerprint

Limb-Girdle Muscular Dystrophies
Founder Effect
Lower Extremity
Genes
Muscles
Frameshift Mutation
Mutation
Muscle Weakness
Vacuoles
Haplotypes
Single Nucleotide Polymorphism
Extremities
Western Blotting
Lipids
Biopsy
2,2,2',4'-tetrachloroacetophenone
Proteins

Keywords

  • Founder effect
  • Limb girdle muscular dystrophy 2G
  • TCAP gene
  • Telethonin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Neurology
  • Clinical Neurology
  • Genetics(clinical)

Cite this

A new case of limb girdle muscular dystrophy 2G in a Greek patient, founder effect and review of the literature. / Brusa, Roberta; Magri, Francesca; Papadimitriou, Dimitra; Govoni, Alessandra; Del Bo, Roberto; Ciscato, Patrizia; Savarese, Marco; Cinnante, Claudia; Walter, Maggie C.; Abicht, Angela; Bulst, Stefanie; Corti, Stefania; Moggio, Maurizio; Bresolin, Nereo; Nigro, Vincenzo; Comi, Giacomo Pietro.

In: Neuromuscular Disorders, Vol. 28, No. 6, 2018, p. 532-537.

Research output: Contribution to journalArticle

Brusa, Roberta ; Magri, Francesca ; Papadimitriou, Dimitra ; Govoni, Alessandra ; Del Bo, Roberto ; Ciscato, Patrizia ; Savarese, Marco ; Cinnante, Claudia ; Walter, Maggie C. ; Abicht, Angela ; Bulst, Stefanie ; Corti, Stefania ; Moggio, Maurizio ; Bresolin, Nereo ; Nigro, Vincenzo ; Comi, Giacomo Pietro. / A new case of limb girdle muscular dystrophy 2G in a Greek patient, founder effect and review of the literature. In: Neuromuscular Disorders. 2018 ; Vol. 28, No. 6. pp. 532-537.
@article{28debca328364030a9379b765426b47a,
title = "A new case of limb girdle muscular dystrophy 2G in a Greek patient, founder effect and review of the literature",
abstract = "Limb girdle muscular dystrophy (LGMD) type 2G is a rare form of muscle disease, described only in a few patients worldwide, caused by mutations in TCAP gene, encoding the protein telethonin. It is characterised by proximal limb muscle weakness associated with distal involvement of lower limbs, starting in the first or second decade of life. We describe the case of a 37-year-old woman of Greek origin, affected by disto-proximal lower limb weakness. No cardiac or respiratory involvement was detected. Muscle biopsy showed myopathic changes with type I fibre hypotrophy, cytoplasmic vacuoles, lipid overload, multiple central nuclei and fibre splittings; ultrastructural examination showed metabolic abnormalities. Next generation sequencing analysis detected a homozygous frameshift mutation in the TCAP gene (c.90_91del), previously described in one Turkish family. Immunostaining and Western blot analysis showed complete absence of telethonin. Interestingly, Single Nucleotide Polymorphism analysis of the 10 Mb genomic region containing the TCAP gene showed a shared homozygous haplotype of both the Greek and the Turkish patients, thus suggesting a possible founder effect of TCAP gene c.90_91del mutation in this part of the Mediterranean area.",
keywords = "Founder effect, Limb girdle muscular dystrophy 2G, TCAP gene, Telethonin",
author = "Roberta Brusa and Francesca Magri and Dimitra Papadimitriou and Alessandra Govoni and {Del Bo}, Roberto and Patrizia Ciscato and Marco Savarese and Claudia Cinnante and Walter, {Maggie C.} and Angela Abicht and Stefanie Bulst and Stefania Corti and Maurizio Moggio and Nereo Bresolin and Vincenzo Nigro and Comi, {Giacomo Pietro}",
year = "2018",
doi = "10.1016/j.nmd.2018.04.006",
language = "English",
volume = "28",
pages = "532--537",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Ltd",
number = "6",

}

TY - JOUR

T1 - A new case of limb girdle muscular dystrophy 2G in a Greek patient, founder effect and review of the literature

AU - Brusa, Roberta

AU - Magri, Francesca

AU - Papadimitriou, Dimitra

AU - Govoni, Alessandra

AU - Del Bo, Roberto

AU - Ciscato, Patrizia

AU - Savarese, Marco

AU - Cinnante, Claudia

AU - Walter, Maggie C.

AU - Abicht, Angela

AU - Bulst, Stefanie

AU - Corti, Stefania

AU - Moggio, Maurizio

AU - Bresolin, Nereo

AU - Nigro, Vincenzo

AU - Comi, Giacomo Pietro

PY - 2018

Y1 - 2018

N2 - Limb girdle muscular dystrophy (LGMD) type 2G is a rare form of muscle disease, described only in a few patients worldwide, caused by mutations in TCAP gene, encoding the protein telethonin. It is characterised by proximal limb muscle weakness associated with distal involvement of lower limbs, starting in the first or second decade of life. We describe the case of a 37-year-old woman of Greek origin, affected by disto-proximal lower limb weakness. No cardiac or respiratory involvement was detected. Muscle biopsy showed myopathic changes with type I fibre hypotrophy, cytoplasmic vacuoles, lipid overload, multiple central nuclei and fibre splittings; ultrastructural examination showed metabolic abnormalities. Next generation sequencing analysis detected a homozygous frameshift mutation in the TCAP gene (c.90_91del), previously described in one Turkish family. Immunostaining and Western blot analysis showed complete absence of telethonin. Interestingly, Single Nucleotide Polymorphism analysis of the 10 Mb genomic region containing the TCAP gene showed a shared homozygous haplotype of both the Greek and the Turkish patients, thus suggesting a possible founder effect of TCAP gene c.90_91del mutation in this part of the Mediterranean area.

AB - Limb girdle muscular dystrophy (LGMD) type 2G is a rare form of muscle disease, described only in a few patients worldwide, caused by mutations in TCAP gene, encoding the protein telethonin. It is characterised by proximal limb muscle weakness associated with distal involvement of lower limbs, starting in the first or second decade of life. We describe the case of a 37-year-old woman of Greek origin, affected by disto-proximal lower limb weakness. No cardiac or respiratory involvement was detected. Muscle biopsy showed myopathic changes with type I fibre hypotrophy, cytoplasmic vacuoles, lipid overload, multiple central nuclei and fibre splittings; ultrastructural examination showed metabolic abnormalities. Next generation sequencing analysis detected a homozygous frameshift mutation in the TCAP gene (c.90_91del), previously described in one Turkish family. Immunostaining and Western blot analysis showed complete absence of telethonin. Interestingly, Single Nucleotide Polymorphism analysis of the 10 Mb genomic region containing the TCAP gene showed a shared homozygous haplotype of both the Greek and the Turkish patients, thus suggesting a possible founder effect of TCAP gene c.90_91del mutation in this part of the Mediterranean area.

KW - Founder effect

KW - Limb girdle muscular dystrophy 2G

KW - TCAP gene

KW - Telethonin

UR - http://www.scopus.com/inward/record.url?scp=85046776942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046776942&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2018.04.006

DO - 10.1016/j.nmd.2018.04.006

M3 - Article

AN - SCOPUS:85046776942

VL - 28

SP - 532

EP - 537

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 6

ER -